Opus Genetics
IRD
35 hedge funds and large institutions have $12.9M invested in Opus Genetics in 2014 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 0 reducing their positions, and 3 closing their positions.
567% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 3
485% more capital invested
Capital invested by funds: $2.21M → $12.9M (+$10.7M)
94% more funds holding
Funds holding: 18 → 35 (+17)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.39M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.78M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$571K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$429K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$375K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$55K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2K |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
26
BlackRock Advisors
Wilmington,
Delaware
| $39K | +$21.1K | +39 | +108% |
|
|
CAS
27
CTC Alternative Strategies
Chicago,
Illinois
| $34.8K | +$36.2K | +67 | New |
|
|
BIT
28
BlackRock Institutional Trust
San Francisco,
California
| $34K | +$35.2K | +65 | New |
|
|
AGM
29
Alpine Global Management
New York
| $22K | +$22.7K | +42 | New |
|
30
Citigroup
New York
| $16K | +$5.41K | +10 | +48% |
|
|
MC
31
Moors & Cabot
Boston,
Massachusetts
| $12K | +$12.4K | +23 | New |
|
|
FNYS
32
First New York Securities
New York
| $11K | +$11.4K | +21 | New |
|
33
Canada Life
Winnipeg,
Manitoba, Canada
| $4K | – | – | – |
|
|
CP
34
Corbenic Partners
Bethlehem,
Pennsylvania
| $2K | +$1.62K | +3 | New |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| $2K | +$2.7K | +5 | New |
|
|
36
Nomura Holdings
Tokyo,
Japan
| – | -$55K | -229 | Closed |
|
|
37
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -9 | Closed |
|
|
38
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$1 | -5 | Closed |
|
IRD Hedge Fund Activity: Q1 2014 in Review
35 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q1 2014, worth a combined $12.9M — up 485% from $2.21M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new IRD positions and 3 closed out — a net gain of 17 holders — while 12 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $2.39M. The largest seller was Nomura Holdings, exiting entirely with an estimated $55K sold.
- 35 institutional investors held Opus Genetics (IRD) as of Q1 2014, up from 18 in Q4 2013.
- Funds reported $12.9M of Opus Genetics stock for Q1 2014, up 485% quarter-over-quarter.
- 20 funds opened new Opus Genetics positions in Q1 2014 and 3 closed out, a net change of +17 holders.
- The largest Opus Genetics buyer in Q1 2014 was Millennium Management, an estimated $2.39M added.
- The largest Opus Genetics seller in Q1 2014 was Nomura Holdings, an estimated $55K sold.
Based on aggregated 13F filings for Q1 2014.